Good seeing more treatment options for CML.
4 Sept 2012 - The U.S. Food and Drug Administration today approved Bosulif (bosutinib) to treat chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects older adults.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm318160.htm
26 Oct 2012 - The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm325895.htm
Both are not yet approved by DCA in Malaysia, let's hope it will be, soon.